ND-09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR-ABL signaling (vol 46, 136, 2021)

被引：0
|
作者：
Liu, Yan-Hong
Zhu, Man
Lei, Pan-Pan
Pan, Xiao-Yan
Ma, Wei-Na
机构：
来源：
ONCOLOGY REPORTS | 2023年 / 49卷 / 05期
关键词：
D O I：
10.3892/or.2023.8518
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Trichosanthin down-regulated p210Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562
    Zhang, Kunzhong
    Xu, Jianhua
    Huang, Xiuwang
    Wu, Lixian
    Wen, Caixia
    Hu, Yingying
    Su, Yu
    Chen, Yuanzhong
    Zhang, Zhiqiang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 581 - 587
  • [32] Trichosanthin down-regulated p210Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562
    Kunzhong Zhang
    Jianhua Xu
    Xiuwang Huang
    Lixian Wu
    Caixia Wen
    Yingying Hu
    Yu Su
    Yuanzhong Chen
    Zhiqiang Zhang
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 581 - 587
  • [33] Phenethyl isothiocyanate inhibits growth of human chronic myeloid leukemia K562 cells via reactive oxygen species generation and caspases
    Wang, Yating
    Wei, Sixi
    Wang, Jishi
    Fang, Qin
    Chai, Qixiang
    MOLECULAR MEDICINE REPORTS, 2014, 10 (01) : 543 - 549
  • [34] CD-200 induces apoptosis and inhibits Bcr-Abl signaling in imatinib-resistant chronic myeloid leukemia with T315I mutation
    Fang, Zhenghuan
    Jung, Kyung Hee
    Yan, Hong Hua
    Kim, Soo Jung
    Son, Mi Kwon
    Rumman, Marufa
    Lee, Hyunseung
    Kim, Ki Woon
    Yoo, Hye-Dong
    Hong, Soon-Sun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (01) : 253 - 261
  • [35] Silencing of BCR/ABL Chimeric Gene in Human Chronic Myelogenous Leukemia Cell Line K562 by siRNA-Nuclear Export Signal Peptide Conjugates
    Shinkai, Yasuhiro
    Kashihara, Shinichi
    Minematsu, Go
    Fujii, Hirofumi
    Naemura, Madoka
    Kotake, Yojiro
    Morita, Yasutaka
    Ohnuki, Koichiro
    Fokina, Alesya A.
    Stetsenko, Dmitry A.
    Filichev, Vyacheslav V.
    Fujii, Masayuki
    NUCLEIC ACID THERAPEUTICS, 2017, 27 (03) : 168 - 175
  • [36] Resveratrol inhibits the phosphatidylinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line
    Sui, Tao
    Ma, Li
    Bai, Xue
    Li, Qing
    Xu, Xinnv
    ONCOLOGY LETTERS, 2014, 7 (06) : 2093 - 2098
  • [37] Allium Roseum L. Extract Exerts Potent Suppressive Activities on Chronic Myeloid Leukemia K562 Cell Viability Through the Inhibition of BCR-ABL, PI3K/Akt, and ERK1/2 Pathways and the Abrogation of VEGF Secretion
    Souid, Soumaya
    Najjaa, Hanen
    Riahi-Chebbi, Ichrak
    Haoues, Meriam
    Neffati, Mohamed
    Arnault, Ingrid
    Auger, Jacques
    Karoui, Habib
    Essafi, Makram
    Essafi-Benkhadir, Khadija
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2017, 69 (01): : 117 - 130
  • [38] Imatinib mesylate (ST1571) abrogates the resistance to doxorubicin in K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
    Majsterek, I
    Blasiak, J
    Slupianek, A
    Skorski, T
    BLOOD, 2005, 106 (11) : 438A - 438A
  • [39] Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair
    Majsterek, I
    Sliwinski, T
    Poplawski, T
    Pytel, D
    Kowalski, M
    Slupianek, A
    Skorski, T
    Blasiak, J
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2006, 603 (01) : 74 - 82
  • [40] Growth suppresion of the chronic myeloid leukemia cell line K562 by ribozyme-mediated cleavage of the transcription factor WT1.
    Huebinger, G
    Maurer, U
    Linorter, S
    Schmid, M
    Manegold, A
    Bergmann, L
    BLOOD, 2000, 96 (11) : 302A - 302A
12345